Lombard Odier & Cie (Bahamas)’s GSK GSK Stock Holding History

Lombard Odier & Cie (Bahamas)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$15K	Hold	320	–	–	0.01%	78
2015 Q2	$17K	Hold	320	–	–	0.01%	82
2015 Q1	$18K	Hold	320	–	–	0.01%	80
2014 Q4	$17K	Hold	320	–	–	0.01%	76
2014 Q3	$18K	Hold	320	–	–	0.01%	82
2014 Q2	$21K	Hold	320	–	–	0.01%	95
2014 Q1	$21K	Hold	320	–	–	0.01%	99
2013 Q4	$21K	Buy	+320	New	+$20.7K	0.01%	105

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lombard Odier & Cie (Bahamas)'s GSK Position: Q3 2015 in Review

Lombard Odier & Cie (Bahamas) held its GSK (GSK) position steady in Q3 2015 at 320 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #78.

Lombard Odier & Cie (Bahamas) first reported a position in GSK in Q4 2013 and has held it in 8 quarters since. The position peaked at $21K in Q2 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

Lombard Odier & Cie (Bahamas) held 320 shares of GSK worth $15K as of Q3 2015.
Lombard Odier & Cie (Bahamas) left its GSK share count unchanged in Q3 2015.
GSK made up 0.01% of Lombard Odier & Cie (Bahamas)'s portfolio in Q3 2015, its #78 holding.
Lombard Odier & Cie (Bahamas) first reported a position in GSK in Q4 2013 and has held it in 8 quarters since.
Lombard Odier & Cie (Bahamas)'s GSK position peaked at $21K in Q2 2014.
706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q3 2015, filed 13 Nov 2015.